steroids 7 1 ( 2 0 0 6 ) 706–711
707
aminolysis with deactivated or aromatic amines as reagents
is especially problematic. Subsequently, several methods have
been developed to enhance the reactivity of epoxides towards
nucleophilic cleavage by aromatic amines. These include the
use of metal triflates [12,13], metal halides [14], zirconium
sulfophenyl phosphonate [15], transition metal based Lewis
acids [16], fluoro alcohols [17] and silica gel [18]. Currently,
ionic liquids are widely used both as solvents and catalysts
in several reactions because of the enhanced reaction rates
and improved selectivities that can be achieved by these
protocols [19,20]. Simple epoxides have also been shown to
undergo smooth ring-opening with aryl amines in various
ionic liquids like 1-butyl-3-methylimidazolium tetrafluorobo-
30.7; 27.8; 21.7; 20.3; 20.2; 15.1; 13.9. MS (m/z/rel. int.): 395
+
(M )/100, 377/23, 364/8, 349/11, 308/13, 160/27, 107/36, 43/28.
IR(CH Cl , ꢀ (cm 1): 3608, 3481, 3419. Analysis calculated for
−
2
2
C26H37NO2 (395.58): C, 78.94; H, 9.43; N, 3.54; found: C, 78.52;
H, 9.68; N, 3.24. Yield: 82%.
ꢀ
3˛-Hydroxy-2ˇ-((4 -hydroxy-phenyl)-amino)-5˛-androst-17-
one (3b). 1H NMR (ı,CDCl ): 6.67(d, 8.3 Hz, 2H, 3 ,5 -H); 6.45(d,
ꢀ
ꢀ
3
ꢀ
ꢀ
8.3 Hz, 2H, 2 ,6 -H); 3.97(brs, 1H, 3-H); 3.45(brs, 1H, 2-H);
2.50–0.60(m, 26H, ring protons); 0.95(s, 3H, 19-H ); 0.80(s, 3H,
3
+
18-H ). MS (m/z/rel. int.): 397(M )/100, 306/34, 162/23, 109/35.
3
Analysis calculated for C25H35NO3 (397.56): C, 75.53; H, 8.87;
N, 3.52; Found: C, 75.20; H, 9.11; N, 3.31. Yield: 56%
3˛-Hydroxy-2ˇ-(phenyl-amino)-5˛-androst-17-one (3c). 1H
+
−
ꢀ ꢀ
rate ([bmim] [BF4] ) or 1-butyl-3-methylimidazolium hexaflu-
NMR(ı,CDCl ): 7.13(t, 8.4 Hz, 2H, 3 ,5 -H); 6.66(t, 8.4 Hz, 1H,
3
+
−
ꢀ
ꢀ
ꢀ
orophosphate ([bmim] [PF6] ) as solvent [21].
4 -H); 6.55(d, 8.4 Hz, 2H, 2 ,6 -H); 3.96(s, 1H, 3-H); 3.55(s, 1H,
In this paper, the application of this latter method to the
regio- and stereoselective ring opening of 2,3-epoxy-steroids
with aromatic amines is presented. The results are compared
to those obtained using conventional organic solvents.
2-H); 2.50–0.60(m, 26H, ring protons); 0.98(s, 3H, 19-H ); 0.82(s,
3
3H, 18-H3) 13C NMR(ı,CDCl ): 220.1; 147.1; 129.3; 117.4; 112.8;
3
68.3; 55.4; 54.4; 51.3; 47.8; 38.8; 38.3; 36.1; 35.2; 34.6; 32.1;
31.5; 30.7; 27.8; 21.7; 20.2; 15.0; 13.9. MS (m/z/rel. int.): 381
+
(
M )/73, 306/100, 288/40, 243/43, 93/72. Analysis calculated for
C25H35NO2 (381.56): C, 78.70; H, 9.24; N, 3.67; found: C, 78.49;
2
.
Experimental
H, 9.01; N, 3.85. Yield: 48%.
ꢀ
3
˛-Hydroxy-2ˇ-((4 -acetyl-phenyl)-amino)-5˛-androst-17-one
1H and 13C NMR spectra were recorded in CDCl3 on a Varian
Inova 400 spectrometer at 400.13 and 100.62 MHz, respectively.
Chemical shifts ı are reported in ppm relative to CHCl3 (7.26
and 77.00 ppm for H and 13C, respectively). GLC analyses were
carried out with a HP-5890/II gas chromatograph using a 15 m
HP-5 column. Infrared (IR) spectra were recorded in KBr pellets
using an Avatar330 FT-IR instrument. Elemental analyses were
measured on a 1108 Carlo Erba apparatus.
1
ꢀ
ꢀ
(3d). H NMR(ı,CDCl ): 7.78(d, 8.4 Hz, 2H, 3 ,5 -H); 6.52(d, 8.4 Hz,
3
ꢀ
ꢀ
2H, 2 ,6 -H); 3.98(brs, 1H, 3-H); 3.67(brs, 1H, 2-H); 2.50–0.65(m,
26H, ring protons); 2.48(s, 3H, C(O)CH ); 0.99(s, 3H, 19-H );
0.83(s, 3H, 18-H3). 13C NMR(ı,CDCl ): 220.1; 196.4; 150.9; 130.9;
3
3
1
3
127.9; 111.5; 67.9; 55.3; 53.8; 51.3; 47.8; 38.6; 37.6; 36.0; 35.7;
34.6; 32.1; 31.5; 30.6; 27.7; 26.0; 21.7; 20.1; 15.1; 13.8. MS (m/z/rel.
+
int.): 423 (M )/78, 408/6, 395/10, 336/8, 308/16, 288/100, 218/55,
139/30. Analysis calculated for C27H37NO3 (423.59): C, 76.56;
H, 8.80; N, 3.31; found: C, 76.11; H, 9.01; N, 3.58.Yield: 45%.
ꢀ
2
.1.
General procedure for the ring opening of epoxides
3˛-Hydroxy-2ˇ-((4 -nitro-phenyl)-amino)-5˛-androst-17-one
1
ꢀ ꢀ
in ionic liquid
(3e). H NMR(ı,CDCl ): 8.05(d, 8.5 Hz, 2H, 3 ,5 -H); 6.62(d, 8.5 Hz,
2
3
ꢀ
ꢀ
H, 2 ,6 -H); 3.97(brs, 1H, 3-H); 3.48(brs, 1H, 2-H); 2.48–0.60(m,
26H, ring protons); 0.95(s, 3H, 19-H ); 0.82(s, 3H, 18-H ). 13C
In a typical procedure, the steroidal epoxide (0.2 mmol), the
3
3
+
−
aromatic amine (0.2 mmol) and 600 mg [bmim] [BF4] were
placed under argon in a Schlenk-tube equipped with a mag-
netic stirrer and a septum inlet and a reflux condenser with
NMR(ı,CDCl ): 221.2; 152.1; 138.0; 126.4; 111.2; 67.7; 55.2; 53.9;
3
51.4; 47.8; 38.5; 37.4; 36.0; 35.7; 34.5; 32.0; 31.4; 30.8; 27.8; 21.7;
20.1; 15.0; 13.8. MS (m/z/rel. int.): 426(M )/100, 396/55, 339/17,
+
a balloon on the top. The reaction mixture was heated at
208/35, 191/50. Analysis calculated for C25H34N O4 (426.55): C,
70.40; H, 8.03; N, 6.57; found: C, 70.77; H, 8.15; N, 6.75. Yield:
56%.
2
◦
1
3
00 C for 8 h. The mixture was extracted three times with
ml diethyl ether. The etheral extract was analyzed by TLC
and after removal of diethyl ether, by 1H NMR. The prod-
ucts were purified by column chromatography (silica gel, ethyl
acetate/hexane (30:70)) and were crystallized from diethyl
ether.
Any volatiles were removed from the ionic liquid in vacuo
and new load of starting materials (steroid and aromatic
amine) for the next run were added to the ionic liquid and
the atmosphere was changed to argon. The consecutive runs
were conducted for the same reaction time.
2ˇ,3˛-Dihydroxy-5˛-androst-17-one (4) was obtained as a side
product and was characterized by 1H and 13C NMR only. The
chemical shifts of 2-H and 3-H as well as those of C-2 and C-3
correspond well to the chemical shifts of the analogous 2,3␣-
dihydroxy-cholestane [22]. 1H NMR(ı,CDCl ): 3.88(m, 2H, 2-H,
3
3-H); 2.50–0.75(m, 26H, ring protons); 0.98(s, 3H, 19-H ); 0.84(s,
3
3H, 18-H3). 13C NMR(ı,CDCl ): 221.2; 71.7; 70.5; 55.3; 51.5; 47.8;
3
40.5; 39.0; 36.2; 35.8; 34.5; 31.8; 31.6; 30.8; 27.9; 21.7; 20.2; 14.5;
13.9.
ꢀ
2
˛,3˛-Epoxy-17-((4 -methyl-phenyl)-imino)-5˛-androstane (5)
2
.2.
Characterization of the products
was obtained as a side product and was characterized by 1H
1
ꢀ
ꢀ
NMR and GC-MS. H NMR(ı,CDCl3): 6.965(d, 8.0 Hz, 2H, 3 ,5 -H);
6.59(d, 8.0 Hz, 2H, 2 ,6 -H); 3.12 (m, 2H, 2-H, 3-H); 2.50–0.60(m,
26H, ring protons); 2.22(s, 3H, 4 -H3); 0.95(s, 3H, 19-H3); 0.78(s,
3H, 18-H3). MS (m/z/rel. int.): 377(M )/83; 362/93; 186/100;
ꢀ
ꢀ
ꢀ
3
(
2
2
3
6
˛-Hydroxy-2ˇ-((4 -methyl-phenyl)-amino)-5˛-androst-17-one
1
ꢀ
ꢀ
ꢀ
3a). H NMR(ı,CDCl3): 6.95(d, 8.4 Hz, 2H, 3 ,5 -H); 6.50(d, 8.4 Hz,
H, 2 ,6 -H); 3.98(brs, 1H, 3-H); 3.51(brs, 1H, 2-H); 2.50–0.75(m,
6H, ring protons); 2.20(s, 3H, 4 -H3); 0.99(s, 3H, 19-H3); 0.83(s,
H, 18-H3). 13C NMR(ı,CDCl3): 221.0; 144.9; 129.9; 126.7; 113.0;
ꢀ
ꢀ
+
ꢀ
144/21; 91/31.
ꢀ
2ˇ-Hydroxy-3˛-((4 -methyl-phenyl)-amino)-5˛-androst-17-one
ꢀ ꢀ
(7). 1H NMR(ı,CDCl3): 6.96(d, 8.4 Hz, 2H, 3 ,5 -H); 6.52(d, 8.4 Hz,
8.4; 55.5; 54.7; 51.3; 47.8; 38.9; 38.5; 36.2; 35.8; 34.6; 32.2; 31.6;